- Home
- LGO vs KYTX Comparison
LGO vs KYTX Comparison
Compare LGO & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- KYTX
- Stock Information
- Founded
- LGO 1988
- KYTX 2018
- Country
- LGO Canada
- KYTX United States
- Employees
- LGO N/A
- KYTX N/A
- Industry
- LGO
- KYTX
- Sector
- LGO
- KYTX
- Exchange
- LGO Nasdaq
- KYTX NYSE
- Market Cap
- LGO 109.0M
- KYTX 125.2M
- IPO Year
- LGO 2007
- KYTX 2024
- Fundamental
- Price
- LGO $1.65
- KYTX $1.93
- Analyst Decision
- LGO Strong Buy
- KYTX Buy
- Analyst Count
- LGO 1
- KYTX 4
- Target Price
- LGO $3.70
- KYTX $19.00
- AVG Volume (30 Days)
- LGO 78.1K
- KYTX 308.0K
- Earning Date
- LGO 05-14-2025
- KYTX 03-27-2025
- Dividend Yield
- LGO N/A
- KYTX N/A
- EPS Growth
- LGO N/A
- KYTX N/A
- EPS
- LGO N/A
- KYTX N/A
- Revenue
- LGO $124,920,000.00
- KYTX N/A
- Revenue This Year
- LGO N/A
- KYTX N/A
- Revenue Next Year
- LGO $33.05
- KYTX N/A
- P/E Ratio
- LGO N/A
- KYTX N/A
- Revenue Growth
- LGO N/A
- KYTX N/A
- 52 Week Low
- LGO $1.38
- KYTX $1.99
- 52 Week High
- LGO $2.84
- KYTX $25.84
- Technical
- Relative Strength Index (RSI)
- LGO 41.53
- KYTX 27.74
- Support Level
- LGO $1.75
- KYTX $2.20
- Resistance Level
- LGO $1.87
- KYTX $2.57
- Average True Range (ATR)
- LGO 0.08
- KYTX 0.19
- MACD
- LGO -0.01
- KYTX -0.02
- Stochastic Oscillator
- LGO 9.38
- KYTX 2.70
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.